Vivani Medical, Inc. (VANI)

1.2100 0.0000 (0.00%) At close: 01:00PM EDT

Vivani Medical, Inc.

1350 South Loop Road
Alameda, CA 94502
United States
415 506 8462
https://www.vivani.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 36

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Adam Mendelsohn Ph.D.	Co-Founder, CEO & Director	609.62k	N/A	1982
Mr. Truc Le M.B.A.	Chief Operations Officer	486.3k	N/A	1953
Dr. Lisa E. Porter M.D.	Chief Medical Officer	482.13k	N/A	1964
Ms. Brigid Ann Makes	Chief Financial Officer	204.63k	N/A	1956
Mr. Donald Dwyer M.B.A.	Chief Business Officer & Corporate Secretary	190.97k	N/A	1959

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Corporate governance

Vivani Medical, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.